New Medicare Program: Full List of Services That Will Need Prior Approval

Medicare is launching a new pilot program that will require prior approval for 17 health services using artificial ...
Investing

Baird downgrades ResMed stock rating to Neutral on slowing growth

Investing.com - Baird downgraded ResMed (NYSE:RMD) from Outperform to Neutral on Tuesday, while lowering its price target to $275.00 from $300.00. Interestingly, this new target aligns closely with ...
Investing

ResMed stock price target raised to $345 from $335 at UBS

Investing.com - UBS raised its price target on ResMed (NYSE:RMD) to $345.00 from $335.00 on Friday, while maintaining a Buy rating on the medical equipment manufacturer’s stock. The new target ...
WDAF-TV

Resmed Receives FDA Clearance for Personalized Therapy Comfort Settings, to be Marketed as Smart Comfort, an AI-Enabled, Digital Medical Device That Helps Personalize CPAP Therapy

SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...